New hope for indian patients with psoriatic arthritis: guselkumab trial launches

NCT ID NCT07141004

Recruiting now Disease control Sponsor: Johnson & Johnson Private Limited Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 3 times

Summary

This study tests a drug called guselkumab in 100 Indian adults with psoriatic arthritis, a condition causing joint pain and swelling. Participants must have tried standard treatments without success. The goal is to see if the drug is safe and helps reduce joint symptoms over 12 weeks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTHRITIS, PSORIATIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psoriatic arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARTHRITIS, PSORIATIC

Contacts and locations

Locations

All India Institute of Medical Sciences
RECRUITING

New Delhi, 110029, India
All India Institute of Medical Sciences
RECRUITING

Patna, 801507, India
All India Institute of Medical Sciences 1
RECRUITING

Gorakhpur, 273008, India
Chennai Meenakshi Multispeciality Hospital
RECRUITING

Chennai, 600004, India
Cims Hospital
RECRUITING

Ahmedabad, 380060, India
ESIC Medical College and Hospital
RECRUITING

Hyderabad, 500038, India
Jehangir Clinical Development Centre
RECRUITING

Pune, 4110001, India
Nizams Institute of Medical Sciences
RECRUITING

Hyderabad, 500082, India
P. D. Hinduja National Hospital and Research Center
RECRUITING

Mumbai, 400016, India
Post Graduate Institute of Medical Education And Research PGIMER
RECRUITING

Chandigarh, India
Sir Ganga Ram Hospital
RECRUITING

New Delhi, 110060, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.